Global Biologics CMO (Contract Manufacturing Organization) Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Biologics CMO (Contract Manufacturing Organization) Services market size was valued at US$ 28667 million in 2025 and is forecast to a readjusted size of US$ 50955 million by 2032 with a CAGR of 8.5% during review period.
Biologics CMO (Contract Manufacturing Organization) Services refer to manufacturing services provided by contract manufacturing organizations under client agreements to biopharmaceutical companies, pharmaceutical companies, and other drug development organizations. These services primarily include biologic drug substance manufacturing, drug product manufacturing, aseptic fill-finish, and other GMP manufacturing activities. The service scope covers antibodies, vaccines, cell and gene therapies, and other biologics, and may support both clinical-stage and commercial-stage production. The market includes contract manufacturing services provided by independent third-party CMOs as well as external manufacturing services offered by in-house CMO business units of pharmaceutical and biopharmaceutical companies. Compared with CDMO services, CMO services are primarily focused on manufacturing execution and production capabilities and generally do not emphasize early-stage drug development, comprehensive process development, formulation development, or other R&D-intensive activities.
Biologics CMO (Contract Manufacturing Organization) services refer to GMP manufacturing services provided under contract to pharmaceutical companies, biotechnology companies, and other drug development organizations. These services primarily cover biologic drug substance (DS) manufacturing, drug product (DP) manufacturing, aseptic fill-finish, packaging, and related quality control activities. By provider type, the industry includes both independent CMOs whose core business is third-party contract manufacturing and in-house CMO business units of large pharmaceutical and biopharmaceutical companies that provide manufacturing capacity to external customers. Compared with CDMOs, CMOs place greater emphasis on process execution following technology transfer, scale-up manufacturing, quality control, and reliable supply, while early-stage drug discovery, systematic process development, and formulation development are generally not their primary functions.
By product type, biologics CMO services mainly cover antibodies, vaccines, cell and gene therapies, and other biologics. Antibodies represent one of the more mature contract manufacturing segments and typically involve mammalian cell culture, harvest, chromatography purification, viral clearance, and drug substance preparation. Vaccine manufacturing involves a wider range of production platforms and process technologies. Cell and gene therapies generally feature smaller batch sizes, more complex processes, stringent quality requirements, and highly customized manufacturing workflows. Consequently, facility design, equipment configuration, biosafety requirements, and quality systems vary significantly across different biologic modalities.
By manufacturing stage, the industry can be divided into biologic drug substance manufacturing and biologic drug product manufacturing. Drug substance manufacturing is generally the more technology- and capital-intensive segment and includes cell culture or microbial fermentation, separation, purification, and bulk drug substance storage. Drug product manufacturing primarily covers formulation, aseptic filling, lyophilization, and filling into vials, prefilled syringes, or cartridges. Some large CMOs have established integrated DS-to-DP manufacturing networks, while other specialized providers focus on large-scale drug substance manufacturing or specific activities such as sterile fill-finish.
Direct customers primarily include large pharmaceutical and biopharmaceutical companies, small and mid-sized pharmaceutical and biotechnology companies, and other drug development organizations. Large pharmaceutical companies generally maintain internal manufacturing capabilities but may outsource production due to capacity constraints, new product introductions, regional supply requirements, specialized manufacturing needs, or efforts to reduce fixed-asset investment. Small and mid-sized biotechnology companies tend to rely more heavily on external manufacturing resources, with CMOs supporting clinical supply, scale-up, and commercial production.
Biologics CMO is an industry characterized by high capital, technical, and regulatory barriers. Mammalian cell culture is a core platform for antibodies and many recombinant proteins. Commercial manufacturing commonly utilizes individual bioreactors ranging from approximately 2,000 L to 20,000 L, while large-scale commercial facilities typically combine multiple bioreactors into a production train. Effective annual capacity per production line depends on the number of bioreactors, culture cycle, product titer, batch success rate, and facility utilization. Single-use bioreactors offer shorter construction timelines, greater flexibility for product changeover, and lower cross-contamination risk, while large stainless-steel systems continue to provide significant economies of scale for mature, high-volume commercial products.
The upstream supply chain primarily consists of cell culture media, single-use bioprocess consumables, bioreactors, filtration systems, chromatography resins and columns, buffer materials, and sterile packaging components. Critical materials such as culture media, single-use consumables, and high-performance chromatography media can materially affect batch consistency and product quality. Major CMOs therefore typically establish multi-supplier strategies and safety stocks for critical materials while increasing facility utilization through standardized platform processes.
Regulatory compliance and quality systems constitute major competitive barriers. Biologics manufacturing must continuously comply with GMP requirements and maintain robust systems for quality management, data integrity, contamination control, process validation, and batch release. Once a commercial product has received regulatory approval and its manufacturing process has been validated at a specific CMO facility, transferring production to another site generally requires additional technology transfer, validation, and regulatory change procedures. The associated time and cost create relatively high customer stickiness and long contract durations for established commercial products.
Key competitive factors include commercial manufacturing experience, GMP compliance track record, manufacturing scale, capacity utilization, technology transfer efficiency, batch success rates, delivery reliability, and global manufacturing networks. Large CMOs with extensive bioreactor capacity and multiple manufacturing sites are well positioned to serve high-volume commercial antibody products, while mid-sized and specialized CMOs differentiate themselves through flexible capacity, small-batch manufacturing, complex molecule capabilities, or specialized technology platforms.
Profitability varies significantly depending on product type, manufacturing scale, capacity utilization, and development stage. Mature commercial biologics generally provide more stable batch demand and higher equipment utilization, whereas clinical-stage projects involve smaller batch volumes, frequent product changeovers, and greater project attrition. Gross margins for established biologics CMO manufacturing operations can generally fall within approximately 20%–40%. Large-scale antibody drug substance manufacturing can achieve stronger economies of scale at high utilization rates, while cell and gene therapy manufacturing and small-batch sterile fill-finish may command higher unit pricing but also require greater labor, quality control, and facility costs.
Future industry growth will be supported by the continued expansion of biologics pipelines, increasing commercialization of antibody drugs and emerging biologic modalities, efforts by pharmaceutical companies to reduce fixed-asset investment, and deeper specialization across pharmaceutical manufacturing networks. At the same time, major CMOs continue to add large-scale 20,000 L-class mammalian cell culture capacity, resulting in greater capacity availability in certain regions. Competition is therefore expected to gradually shift from pure capacity expansion toward a broader focus on capacity utilization, manufacturing efficiency, quality consistency, supply reliability, and lifecycle manufacturing capabilities.
Global Biologics CMO (Contract Manufacturing Organization) Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biologics CMO (Contract Manufacturing Organization) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biologics CMO (Contract Manufacturing Organization) Services market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Biologics CMO (Contract Manufacturing Organization) Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top players of Biologics CMO (Contract Manufacturing Organization) Services, with revenue, gross margin, and global market share of Biologics CMO (Contract Manufacturing Organization) Services from 2021 to 2026.
Chapter 3, the Biologics CMO (Contract Manufacturing Organization) Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biologics CMO (Contract Manufacturing Organization) Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics CMO (Contract Manufacturing Organization) Services.
Chapter 13, to describe Biologics CMO (Contract Manufacturing Organization) Services research findings and conclusion.
Biologics CMO (Contract Manufacturing Organization) Services refer to manufacturing services provided by contract manufacturing organizations under client agreements to biopharmaceutical companies, pharmaceutical companies, and other drug development organizations. These services primarily include biologic drug substance manufacturing, drug product manufacturing, aseptic fill-finish, and other GMP manufacturing activities. The service scope covers antibodies, vaccines, cell and gene therapies, and other biologics, and may support both clinical-stage and commercial-stage production. The market includes contract manufacturing services provided by independent third-party CMOs as well as external manufacturing services offered by in-house CMO business units of pharmaceutical and biopharmaceutical companies. Compared with CDMO services, CMO services are primarily focused on manufacturing execution and production capabilities and generally do not emphasize early-stage drug development, comprehensive process development, formulation development, or other R&D-intensive activities.
Biologics CMO (Contract Manufacturing Organization) services refer to GMP manufacturing services provided under contract to pharmaceutical companies, biotechnology companies, and other drug development organizations. These services primarily cover biologic drug substance (DS) manufacturing, drug product (DP) manufacturing, aseptic fill-finish, packaging, and related quality control activities. By provider type, the industry includes both independent CMOs whose core business is third-party contract manufacturing and in-house CMO business units of large pharmaceutical and biopharmaceutical companies that provide manufacturing capacity to external customers. Compared with CDMOs, CMOs place greater emphasis on process execution following technology transfer, scale-up manufacturing, quality control, and reliable supply, while early-stage drug discovery, systematic process development, and formulation development are generally not their primary functions.
By product type, biologics CMO services mainly cover antibodies, vaccines, cell and gene therapies, and other biologics. Antibodies represent one of the more mature contract manufacturing segments and typically involve mammalian cell culture, harvest, chromatography purification, viral clearance, and drug substance preparation. Vaccine manufacturing involves a wider range of production platforms and process technologies. Cell and gene therapies generally feature smaller batch sizes, more complex processes, stringent quality requirements, and highly customized manufacturing workflows. Consequently, facility design, equipment configuration, biosafety requirements, and quality systems vary significantly across different biologic modalities.
By manufacturing stage, the industry can be divided into biologic drug substance manufacturing and biologic drug product manufacturing. Drug substance manufacturing is generally the more technology- and capital-intensive segment and includes cell culture or microbial fermentation, separation, purification, and bulk drug substance storage. Drug product manufacturing primarily covers formulation, aseptic filling, lyophilization, and filling into vials, prefilled syringes, or cartridges. Some large CMOs have established integrated DS-to-DP manufacturing networks, while other specialized providers focus on large-scale drug substance manufacturing or specific activities such as sterile fill-finish.
Direct customers primarily include large pharmaceutical and biopharmaceutical companies, small and mid-sized pharmaceutical and biotechnology companies, and other drug development organizations. Large pharmaceutical companies generally maintain internal manufacturing capabilities but may outsource production due to capacity constraints, new product introductions, regional supply requirements, specialized manufacturing needs, or efforts to reduce fixed-asset investment. Small and mid-sized biotechnology companies tend to rely more heavily on external manufacturing resources, with CMOs supporting clinical supply, scale-up, and commercial production.
Biologics CMO is an industry characterized by high capital, technical, and regulatory barriers. Mammalian cell culture is a core platform for antibodies and many recombinant proteins. Commercial manufacturing commonly utilizes individual bioreactors ranging from approximately 2,000 L to 20,000 L, while large-scale commercial facilities typically combine multiple bioreactors into a production train. Effective annual capacity per production line depends on the number of bioreactors, culture cycle, product titer, batch success rate, and facility utilization. Single-use bioreactors offer shorter construction timelines, greater flexibility for product changeover, and lower cross-contamination risk, while large stainless-steel systems continue to provide significant economies of scale for mature, high-volume commercial products.
The upstream supply chain primarily consists of cell culture media, single-use bioprocess consumables, bioreactors, filtration systems, chromatography resins and columns, buffer materials, and sterile packaging components. Critical materials such as culture media, single-use consumables, and high-performance chromatography media can materially affect batch consistency and product quality. Major CMOs therefore typically establish multi-supplier strategies and safety stocks for critical materials while increasing facility utilization through standardized platform processes.
Regulatory compliance and quality systems constitute major competitive barriers. Biologics manufacturing must continuously comply with GMP requirements and maintain robust systems for quality management, data integrity, contamination control, process validation, and batch release. Once a commercial product has received regulatory approval and its manufacturing process has been validated at a specific CMO facility, transferring production to another site generally requires additional technology transfer, validation, and regulatory change procedures. The associated time and cost create relatively high customer stickiness and long contract durations for established commercial products.
Key competitive factors include commercial manufacturing experience, GMP compliance track record, manufacturing scale, capacity utilization, technology transfer efficiency, batch success rates, delivery reliability, and global manufacturing networks. Large CMOs with extensive bioreactor capacity and multiple manufacturing sites are well positioned to serve high-volume commercial antibody products, while mid-sized and specialized CMOs differentiate themselves through flexible capacity, small-batch manufacturing, complex molecule capabilities, or specialized technology platforms.
Profitability varies significantly depending on product type, manufacturing scale, capacity utilization, and development stage. Mature commercial biologics generally provide more stable batch demand and higher equipment utilization, whereas clinical-stage projects involve smaller batch volumes, frequent product changeovers, and greater project attrition. Gross margins for established biologics CMO manufacturing operations can generally fall within approximately 20%–40%. Large-scale antibody drug substance manufacturing can achieve stronger economies of scale at high utilization rates, while cell and gene therapy manufacturing and small-batch sterile fill-finish may command higher unit pricing but also require greater labor, quality control, and facility costs.
Future industry growth will be supported by the continued expansion of biologics pipelines, increasing commercialization of antibody drugs and emerging biologic modalities, efforts by pharmaceutical companies to reduce fixed-asset investment, and deeper specialization across pharmaceutical manufacturing networks. At the same time, major CMOs continue to add large-scale 20,000 L-class mammalian cell culture capacity, resulting in greater capacity availability in certain regions. Competition is therefore expected to gradually shift from pure capacity expansion toward a broader focus on capacity utilization, manufacturing efficiency, quality consistency, supply reliability, and lifecycle manufacturing capabilities.
Report Scope
This report is a detailed and comprehensive analysis for global Biologics CMO (Contract Manufacturing Organization) Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Biologics CMO (Contract Manufacturing Organization) Services market size and forecasts, in consumption value ($ Million), 2021-2032Global Biologics CMO (Contract Manufacturing Organization) Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biologics CMO (Contract Manufacturing Organization) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biologics CMO (Contract Manufacturing Organization) Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Biologics CMO (Contract Manufacturing Organization) Services
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Biologics CMO (Contract Manufacturing Organization) Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Others
Market segment by CMO Provider Type
- In-house CMO
- Independent CMO
Market segment by Manufacturing Stage
- Drug Substance (DS) Manufacturing
- Drug Product (DP) Manufacturing
Market segment by Application
- Large Pharmaceutical and Biopharmaceutical Companies
- Small and Mid-sized Pharmaceutical and Biotechnology Companies
- Others
Market segment by players, this report covers
- Lonza Group AG
- Samsung Biologics Co., Ltd.
- FUJIFILM Biotechnologies
- Boehringer Ingelheim BioXcellence
- WuXi Biologics (Cayman) Inc.
- Thermo Fisher Scientific – Patheon Pharma Services
- Catalent, Inc.
- AGC Biologics
- National Resilience, Inc.
- Vetter Pharma International GmbH
- Rentschler Biopharma SE
- KBI Biopharma, Inc.
- LOTTE BIOLOGICS Co., Ltd.
- Pfizer CentreOne
- AbbVie Contract Manufacturing
- Syngene International Limited
- Avid Bioservices, Inc.
- Recipharm Advanced Bio
- Ajinomoto Bio-Pharma Services
- Wacker Biotech GmbH
- Bora Biologics
- 3PBIOVIAN
- Fareva
- Aenova Group
- Siegfried Holding AG
- GenScript ProBio
- Chime Biologics (Wuhan) Co., Ltd.
- MabPlex International
- Pharmaron Beijing Co., Ltd.
- Thousand Oaks Biologics Inc.
- Cytovance Biologics, Inc.
- Porton Pharma Solutions Ltd.
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Biologics CMO (Contract Manufacturing Organization) Services product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Biologics CMO (Contract Manufacturing Organization) Services, with revenue, gross margin, and global market share of Biologics CMO (Contract Manufacturing Organization) Services from 2021 to 2026.
Chapter 3, the Biologics CMO (Contract Manufacturing Organization) Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biologics CMO (Contract Manufacturing Organization) Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics CMO (Contract Manufacturing Organization) Services.
Chapter 13, to describe Biologics CMO (Contract Manufacturing Organization) Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics CMO (Contract Manufacturing Organization) Services by Type
1.3.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type in 2025
1.3.3 Cell and Gene Therapies
1.3.4 Antibodies
1.3.5 Vaccines
1.3.6 Others
1.4 Classification of Biologics CMO (Contract Manufacturing Organization) Services by CMO Provider Type
1.4.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type: 2021 Versus 2025 Versus 2032
1.4.2 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by CMO Provider Type in 2025
1.4.3 In-house CMO
1.4.4 Independent CMO
1.5 Classification of Biologics CMO (Contract Manufacturing Organization) Services by Manufacturing Stage
1.5.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage: 2021 Versus 2025 Versus 2032
1.5.2 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Manufacturing Stage in 2025
1.5.3 Drug Substance (DS) Manufacturing
1.5.4 Drug Product (DP) Manufacturing
1.6 Global Biologics CMO (Contract Manufacturing Organization) Services Market by Application
1.6.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Large Pharmaceutical and Biopharmaceutical Companies
1.6.3 Small and Mid-sized Pharmaceutical and Biotechnology Companies
1.6.4 Others
1.7 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size & Forecast
1.8 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast by Region
1.8.1 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region, (2021-2032)
1.8.3 North America Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.4 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.6 South America Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Lonza Group AG
2.1.1 Lonza Group AG Details
2.1.2 Lonza Group AG Major Business
2.1.3 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.1.4 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Lonza Group AG Recent Developments and Future Plans
2.2 Samsung Biologics Co., Ltd.
2.2.1 Samsung Biologics Co., Ltd. Details
2.2.2 Samsung Biologics Co., Ltd. Major Business
2.2.3 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.2.4 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Samsung Biologics Co., Ltd. Recent Developments and Future Plans
2.3 FUJIFILM Biotechnologies
2.3.1 FUJIFILM Biotechnologies Details
2.3.2 FUJIFILM Biotechnologies Major Business
2.3.3 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.3.4 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 FUJIFILM Biotechnologies Recent Developments and Future Plans
2.4 Boehringer Ingelheim BioXcellence
2.4.1 Boehringer Ingelheim BioXcellence Details
2.4.2 Boehringer Ingelheim BioXcellence Major Business
2.4.3 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.4.4 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
2.5 WuXi Biologics (Cayman) Inc.
2.5.1 WuXi Biologics (Cayman) Inc. Details
2.5.2 WuXi Biologics (Cayman) Inc. Major Business
2.5.3 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.5.4 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 WuXi Biologics (Cayman) Inc. Recent Developments and Future Plans
2.6 Thermo Fisher Scientific – Patheon Pharma Services
2.6.1 Thermo Fisher Scientific – Patheon Pharma Services Details
2.6.2 Thermo Fisher Scientific – Patheon Pharma Services Major Business
2.6.3 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.6.4 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Thermo Fisher Scientific – Patheon Pharma Services Recent Developments and Future Plans
2.7 Catalent, Inc.
2.7.1 Catalent, Inc. Details
2.7.2 Catalent, Inc. Major Business
2.7.3 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.7.4 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Catalent, Inc. Recent Developments and Future Plans
2.8 AGC Biologics
2.8.1 AGC Biologics Details
2.8.2 AGC Biologics Major Business
2.8.3 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.8.4 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 AGC Biologics Recent Developments and Future Plans
2.9 National Resilience, Inc.
2.9.1 National Resilience, Inc. Details
2.9.2 National Resilience, Inc. Major Business
2.9.3 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.9.4 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 National Resilience, Inc. Recent Developments and Future Plans
2.10 Vetter Pharma International GmbH
2.10.1 Vetter Pharma International GmbH Details
2.10.2 Vetter Pharma International GmbH Major Business
2.10.3 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.10.4 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vetter Pharma International GmbH Recent Developments and Future Plans
2.11 Rentschler Biopharma SE
2.11.1 Rentschler Biopharma SE Details
2.11.2 Rentschler Biopharma SE Major Business
2.11.3 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.11.4 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Rentschler Biopharma SE Recent Developments and Future Plans
2.12 KBI Biopharma, Inc.
2.12.1 KBI Biopharma, Inc. Details
2.12.2 KBI Biopharma, Inc. Major Business
2.12.3 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.12.4 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 KBI Biopharma, Inc. Recent Developments and Future Plans
2.13 LOTTE BIOLOGICS Co., Ltd.
2.13.1 LOTTE BIOLOGICS Co., Ltd. Details
2.13.2 LOTTE BIOLOGICS Co., Ltd. Major Business
2.13.3 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.13.4 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 LOTTE BIOLOGICS Co., Ltd. Recent Developments and Future Plans
2.14 Pfizer CentreOne
2.14.1 Pfizer CentreOne Details
2.14.2 Pfizer CentreOne Major Business
2.14.3 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.14.4 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Pfizer CentreOne Recent Developments and Future Plans
2.15 AbbVie Contract Manufacturing
2.15.1 AbbVie Contract Manufacturing Details
2.15.2 AbbVie Contract Manufacturing Major Business
2.15.3 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.15.4 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 AbbVie Contract Manufacturing Recent Developments and Future Plans
2.16 Syngene International Limited
2.16.1 Syngene International Limited Details
2.16.2 Syngene International Limited Major Business
2.16.3 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.16.4 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Syngene International Limited Recent Developments and Future Plans
2.17 Avid Bioservices, Inc.
2.17.1 Avid Bioservices, Inc. Details
2.17.2 Avid Bioservices, Inc. Major Business
2.17.3 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.17.4 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Avid Bioservices, Inc. Recent Developments and Future Plans
2.18 Recipharm Advanced Bio
2.18.1 Recipharm Advanced Bio Details
2.18.2 Recipharm Advanced Bio Major Business
2.18.3 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.18.4 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Recipharm Advanced Bio Recent Developments and Future Plans
2.19 Ajinomoto Bio-Pharma Services
2.19.1 Ajinomoto Bio-Pharma Services Details
2.19.2 Ajinomoto Bio-Pharma Services Major Business
2.19.3 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.19.4 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
2.20 Wacker Biotech GmbH
2.20.1 Wacker Biotech GmbH Details
2.20.2 Wacker Biotech GmbH Major Business
2.20.3 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.20.4 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Wacker Biotech GmbH Recent Developments and Future Plans
2.21 Bora Biologics
2.21.1 Bora Biologics Details
2.21.2 Bora Biologics Major Business
2.21.3 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.21.4 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Bora Biologics Recent Developments and Future Plans
2.22 3PBIOVIAN
2.22.1 3PBIOVIAN Details
2.22.2 3PBIOVIAN Major Business
2.22.3 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.22.4 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 3PBIOVIAN Recent Developments and Future Plans
2.23 Fareva
2.23.1 Fareva Details
2.23.2 Fareva Major Business
2.23.3 Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.23.4 Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Fareva Recent Developments and Future Plans
2.24 Aenova Group
2.24.1 Aenova Group Details
2.24.2 Aenova Group Major Business
2.24.3 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.24.4 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Aenova Group Recent Developments and Future Plans
2.25 Siegfried Holding AG
2.25.1 Siegfried Holding AG Details
2.25.2 Siegfried Holding AG Major Business
2.25.3 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.25.4 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Siegfried Holding AG Recent Developments and Future Plans
2.26 GenScript ProBio
2.26.1 GenScript ProBio Details
2.26.2 GenScript ProBio Major Business
2.26.3 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.26.4 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 GenScript ProBio Recent Developments and Future Plans
2.27 Chime Biologics (Wuhan) Co., Ltd.
2.27.1 Chime Biologics (Wuhan) Co., Ltd. Details
2.27.2 Chime Biologics (Wuhan) Co., Ltd. Major Business
2.27.3 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.27.4 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Chime Biologics (Wuhan) Co., Ltd. Recent Developments and Future Plans
2.28 MabPlex International
2.28.1 MabPlex International Details
2.28.2 MabPlex International Major Business
2.28.3 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.28.4 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 MabPlex International Recent Developments and Future Plans
2.29 Pharmaron Beijing Co., Ltd.
2.29.1 Pharmaron Beijing Co., Ltd. Details
2.29.2 Pharmaron Beijing Co., Ltd. Major Business
2.29.3 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.29.4 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 Pharmaron Beijing Co., Ltd. Recent Developments and Future Plans
2.30 Thousand Oaks Biologics Inc.
2.30.1 Thousand Oaks Biologics Inc. Details
2.30.2 Thousand Oaks Biologics Inc. Major Business
2.30.3 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.30.4 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Thousand Oaks Biologics Inc. Recent Developments and Future Plans
2.31 Cytovance Biologics, Inc.
2.31.1 Cytovance Biologics, Inc. Details
2.31.2 Cytovance Biologics, Inc. Major Business
2.31.3 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.31.4 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Cytovance Biologics, Inc. Recent Developments and Future Plans
2.32 Porton Pharma Solutions Ltd.
2.32.1 Porton Pharma Solutions Ltd. Details
2.32.2 Porton Pharma Solutions Ltd. Major Business
2.32.3 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.32.4 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 Porton Pharma Solutions Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologics CMO (Contract Manufacturing Organization) Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Biologics CMO (Contract Manufacturing Organization) Services by Company Revenue
3.2.2 Top 3 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
3.2.3 Top 6 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
3.3 Biologics CMO (Contract Manufacturing Organization) Services Market: Overall Company Footprint Analysis
3.3.1 Biologics CMO (Contract Manufacturing Organization) Services Market: Region Footprint
3.3.2 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
3.3.3 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
6.2 North America Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2032)
6.3 North America Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
6.3.1 North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
6.3.2 United States Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
6.3.3 Canada Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
7.2 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
7.3 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
7.3.1 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
7.3.2 Germany Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.3 France Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.5 Russia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.6 Italy Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region
8.3.1 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2032)
8.3.2 China Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.3 Japan Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.5 India Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.7 Australia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
9.2 South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
9.3 South America Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
9.3.1 South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
10.3.1 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
10.3.4 UAE Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
11.2 Biologics CMO (Contract Manufacturing Organization) Services Market Restraints
11.3 Biologics CMO (Contract Manufacturing Organization) Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologics CMO (Contract Manufacturing Organization) Services Industry Chain
12.2 Biologics CMO (Contract Manufacturing Organization) Services Upstream Analysis
12.3 Biologics CMO (Contract Manufacturing Organization) Services Midstream Analysis
12.4 Biologics CMO (Contract Manufacturing Organization) Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics CMO (Contract Manufacturing Organization) Services by Type
1.3.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type in 2025
1.3.3 Cell and Gene Therapies
1.3.4 Antibodies
1.3.5 Vaccines
1.3.6 Others
1.4 Classification of Biologics CMO (Contract Manufacturing Organization) Services by CMO Provider Type
1.4.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type: 2021 Versus 2025 Versus 2032
1.4.2 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by CMO Provider Type in 2025
1.4.3 In-house CMO
1.4.4 Independent CMO
1.5 Classification of Biologics CMO (Contract Manufacturing Organization) Services by Manufacturing Stage
1.5.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage: 2021 Versus 2025 Versus 2032
1.5.2 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Manufacturing Stage in 2025
1.5.3 Drug Substance (DS) Manufacturing
1.5.4 Drug Product (DP) Manufacturing
1.6 Global Biologics CMO (Contract Manufacturing Organization) Services Market by Application
1.6.1 Overview: Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Large Pharmaceutical and Biopharmaceutical Companies
1.6.3 Small and Mid-sized Pharmaceutical and Biotechnology Companies
1.6.4 Others
1.7 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size & Forecast
1.8 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast by Region
1.8.1 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region, (2021-2032)
1.8.3 North America Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.4 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.6 South America Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Lonza Group AG
2.1.1 Lonza Group AG Details
2.1.2 Lonza Group AG Major Business
2.1.3 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.1.4 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Lonza Group AG Recent Developments and Future Plans
2.2 Samsung Biologics Co., Ltd.
2.2.1 Samsung Biologics Co., Ltd. Details
2.2.2 Samsung Biologics Co., Ltd. Major Business
2.2.3 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.2.4 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Samsung Biologics Co., Ltd. Recent Developments and Future Plans
2.3 FUJIFILM Biotechnologies
2.3.1 FUJIFILM Biotechnologies Details
2.3.2 FUJIFILM Biotechnologies Major Business
2.3.3 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.3.4 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 FUJIFILM Biotechnologies Recent Developments and Future Plans
2.4 Boehringer Ingelheim BioXcellence
2.4.1 Boehringer Ingelheim BioXcellence Details
2.4.2 Boehringer Ingelheim BioXcellence Major Business
2.4.3 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.4.4 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
2.5 WuXi Biologics (Cayman) Inc.
2.5.1 WuXi Biologics (Cayman) Inc. Details
2.5.2 WuXi Biologics (Cayman) Inc. Major Business
2.5.3 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.5.4 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 WuXi Biologics (Cayman) Inc. Recent Developments and Future Plans
2.6 Thermo Fisher Scientific – Patheon Pharma Services
2.6.1 Thermo Fisher Scientific – Patheon Pharma Services Details
2.6.2 Thermo Fisher Scientific – Patheon Pharma Services Major Business
2.6.3 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.6.4 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Thermo Fisher Scientific – Patheon Pharma Services Recent Developments and Future Plans
2.7 Catalent, Inc.
2.7.1 Catalent, Inc. Details
2.7.2 Catalent, Inc. Major Business
2.7.3 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.7.4 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Catalent, Inc. Recent Developments and Future Plans
2.8 AGC Biologics
2.8.1 AGC Biologics Details
2.8.2 AGC Biologics Major Business
2.8.3 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.8.4 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 AGC Biologics Recent Developments and Future Plans
2.9 National Resilience, Inc.
2.9.1 National Resilience, Inc. Details
2.9.2 National Resilience, Inc. Major Business
2.9.3 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.9.4 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 National Resilience, Inc. Recent Developments and Future Plans
2.10 Vetter Pharma International GmbH
2.10.1 Vetter Pharma International GmbH Details
2.10.2 Vetter Pharma International GmbH Major Business
2.10.3 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.10.4 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vetter Pharma International GmbH Recent Developments and Future Plans
2.11 Rentschler Biopharma SE
2.11.1 Rentschler Biopharma SE Details
2.11.2 Rentschler Biopharma SE Major Business
2.11.3 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.11.4 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Rentschler Biopharma SE Recent Developments and Future Plans
2.12 KBI Biopharma, Inc.
2.12.1 KBI Biopharma, Inc. Details
2.12.2 KBI Biopharma, Inc. Major Business
2.12.3 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.12.4 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 KBI Biopharma, Inc. Recent Developments and Future Plans
2.13 LOTTE BIOLOGICS Co., Ltd.
2.13.1 LOTTE BIOLOGICS Co., Ltd. Details
2.13.2 LOTTE BIOLOGICS Co., Ltd. Major Business
2.13.3 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.13.4 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 LOTTE BIOLOGICS Co., Ltd. Recent Developments and Future Plans
2.14 Pfizer CentreOne
2.14.1 Pfizer CentreOne Details
2.14.2 Pfizer CentreOne Major Business
2.14.3 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.14.4 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Pfizer CentreOne Recent Developments and Future Plans
2.15 AbbVie Contract Manufacturing
2.15.1 AbbVie Contract Manufacturing Details
2.15.2 AbbVie Contract Manufacturing Major Business
2.15.3 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.15.4 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 AbbVie Contract Manufacturing Recent Developments and Future Plans
2.16 Syngene International Limited
2.16.1 Syngene International Limited Details
2.16.2 Syngene International Limited Major Business
2.16.3 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.16.4 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Syngene International Limited Recent Developments and Future Plans
2.17 Avid Bioservices, Inc.
2.17.1 Avid Bioservices, Inc. Details
2.17.2 Avid Bioservices, Inc. Major Business
2.17.3 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.17.4 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Avid Bioservices, Inc. Recent Developments and Future Plans
2.18 Recipharm Advanced Bio
2.18.1 Recipharm Advanced Bio Details
2.18.2 Recipharm Advanced Bio Major Business
2.18.3 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.18.4 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Recipharm Advanced Bio Recent Developments and Future Plans
2.19 Ajinomoto Bio-Pharma Services
2.19.1 Ajinomoto Bio-Pharma Services Details
2.19.2 Ajinomoto Bio-Pharma Services Major Business
2.19.3 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.19.4 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
2.20 Wacker Biotech GmbH
2.20.1 Wacker Biotech GmbH Details
2.20.2 Wacker Biotech GmbH Major Business
2.20.3 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.20.4 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Wacker Biotech GmbH Recent Developments and Future Plans
2.21 Bora Biologics
2.21.1 Bora Biologics Details
2.21.2 Bora Biologics Major Business
2.21.3 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.21.4 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Bora Biologics Recent Developments and Future Plans
2.22 3PBIOVIAN
2.22.1 3PBIOVIAN Details
2.22.2 3PBIOVIAN Major Business
2.22.3 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.22.4 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 3PBIOVIAN Recent Developments and Future Plans
2.23 Fareva
2.23.1 Fareva Details
2.23.2 Fareva Major Business
2.23.3 Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.23.4 Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Fareva Recent Developments and Future Plans
2.24 Aenova Group
2.24.1 Aenova Group Details
2.24.2 Aenova Group Major Business
2.24.3 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.24.4 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Aenova Group Recent Developments and Future Plans
2.25 Siegfried Holding AG
2.25.1 Siegfried Holding AG Details
2.25.2 Siegfried Holding AG Major Business
2.25.3 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.25.4 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Siegfried Holding AG Recent Developments and Future Plans
2.26 GenScript ProBio
2.26.1 GenScript ProBio Details
2.26.2 GenScript ProBio Major Business
2.26.3 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.26.4 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 GenScript ProBio Recent Developments and Future Plans
2.27 Chime Biologics (Wuhan) Co., Ltd.
2.27.1 Chime Biologics (Wuhan) Co., Ltd. Details
2.27.2 Chime Biologics (Wuhan) Co., Ltd. Major Business
2.27.3 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.27.4 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Chime Biologics (Wuhan) Co., Ltd. Recent Developments and Future Plans
2.28 MabPlex International
2.28.1 MabPlex International Details
2.28.2 MabPlex International Major Business
2.28.3 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.28.4 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 MabPlex International Recent Developments and Future Plans
2.29 Pharmaron Beijing Co., Ltd.
2.29.1 Pharmaron Beijing Co., Ltd. Details
2.29.2 Pharmaron Beijing Co., Ltd. Major Business
2.29.3 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.29.4 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 Pharmaron Beijing Co., Ltd. Recent Developments and Future Plans
2.30 Thousand Oaks Biologics Inc.
2.30.1 Thousand Oaks Biologics Inc. Details
2.30.2 Thousand Oaks Biologics Inc. Major Business
2.30.3 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.30.4 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Thousand Oaks Biologics Inc. Recent Developments and Future Plans
2.31 Cytovance Biologics, Inc.
2.31.1 Cytovance Biologics, Inc. Details
2.31.2 Cytovance Biologics, Inc. Major Business
2.31.3 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.31.4 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Cytovance Biologics, Inc. Recent Developments and Future Plans
2.32 Porton Pharma Solutions Ltd.
2.32.1 Porton Pharma Solutions Ltd. Details
2.32.2 Porton Pharma Solutions Ltd. Major Business
2.32.3 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
2.32.4 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 Porton Pharma Solutions Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologics CMO (Contract Manufacturing Organization) Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Biologics CMO (Contract Manufacturing Organization) Services by Company Revenue
3.2.2 Top 3 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
3.2.3 Top 6 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
3.3 Biologics CMO (Contract Manufacturing Organization) Services Market: Overall Company Footprint Analysis
3.3.1 Biologics CMO (Contract Manufacturing Organization) Services Market: Region Footprint
3.3.2 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
3.3.3 Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
6.2 North America Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2032)
6.3 North America Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
6.3.1 North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
6.3.2 United States Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
6.3.3 Canada Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
7.2 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
7.3 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
7.3.1 Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
7.3.2 Germany Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.3 France Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.5 Russia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
7.3.6 Italy Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region
8.3.1 Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2032)
8.3.2 China Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.3 Japan Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.5 India Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
8.3.7 Australia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
9.2 South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
9.3 South America Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
9.3.1 South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country
10.3.1 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
10.3.4 UAE Biologics CMO (Contract Manufacturing Organization) Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
11.2 Biologics CMO (Contract Manufacturing Organization) Services Market Restraints
11.3 Biologics CMO (Contract Manufacturing Organization) Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologics CMO (Contract Manufacturing Organization) Services Industry Chain
12.2 Biologics CMO (Contract Manufacturing Organization) Services Upstream Analysis
12.3 Biologics CMO (Contract Manufacturing Organization) Services Midstream Analysis
12.4 Biologics CMO (Contract Manufacturing Organization) Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 8. Lonza Group AG Major Business
Table 9. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 10. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Lonza Group AG Recent Developments and Future Plans
Table 12. Samsung Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 13. Samsung Biologics Co., Ltd. Major Business
Table 14. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 15. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Samsung Biologics Co., Ltd. Recent Developments and Future Plans
Table 17. FUJIFILM Biotechnologies Company Information, Head Office, and Major Competitors
Table 18. FUJIFILM Biotechnologies Major Business
Table 19. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 20. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Boehringer Ingelheim BioXcellence Company Information, Head Office, and Major Competitors
Table 22. Boehringer Ingelheim BioXcellence Major Business
Table 23. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 24. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
Table 26. WuXi Biologics (Cayman) Inc. Company Information, Head Office, and Major Competitors
Table 27. WuXi Biologics (Cayman) Inc. Major Business
Table 28. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 29. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. WuXi Biologics (Cayman) Inc. Recent Developments and Future Plans
Table 31. Thermo Fisher Scientific – Patheon Pharma Services Company Information, Head Office, and Major Competitors
Table 32. Thermo Fisher Scientific – Patheon Pharma Services Major Business
Table 33. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 34. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Thermo Fisher Scientific – Patheon Pharma Services Recent Developments and Future Plans
Table 36. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 37. Catalent, Inc. Major Business
Table 38. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 39. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Catalent, Inc. Recent Developments and Future Plans
Table 41. AGC Biologics Company Information, Head Office, and Major Competitors
Table 42. AGC Biologics Major Business
Table 43. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 44. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. AGC Biologics Recent Developments and Future Plans
Table 46. National Resilience, Inc. Company Information, Head Office, and Major Competitors
Table 47. National Resilience, Inc. Major Business
Table 48. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 49. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. National Resilience, Inc. Recent Developments and Future Plans
Table 51. Vetter Pharma International GmbH Company Information, Head Office, and Major Competitors
Table 52. Vetter Pharma International GmbH Major Business
Table 53. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 54. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Vetter Pharma International GmbH Recent Developments and Future Plans
Table 56. Rentschler Biopharma SE Company Information, Head Office, and Major Competitors
Table 57. Rentschler Biopharma SE Major Business
Table 58. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 59. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Rentschler Biopharma SE Recent Developments and Future Plans
Table 61. KBI Biopharma, Inc. Company Information, Head Office, and Major Competitors
Table 62. KBI Biopharma, Inc. Major Business
Table 63. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 64. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. KBI Biopharma, Inc. Recent Developments and Future Plans
Table 66. LOTTE BIOLOGICS Co., Ltd. Company Information, Head Office, and Major Competitors
Table 67. LOTTE BIOLOGICS Co., Ltd. Major Business
Table 68. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 69. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. LOTTE BIOLOGICS Co., Ltd. Recent Developments and Future Plans
Table 71. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 72. Pfizer CentreOne Major Business
Table 73. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 74. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Pfizer CentreOne Recent Developments and Future Plans
Table 76. AbbVie Contract Manufacturing Company Information, Head Office, and Major Competitors
Table 77. AbbVie Contract Manufacturing Major Business
Table 78. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 79. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. AbbVie Contract Manufacturing Recent Developments and Future Plans
Table 81. Syngene International Limited Company Information, Head Office, and Major Competitors
Table 82. Syngene International Limited Major Business
Table 83. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 84. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Syngene International Limited Recent Developments and Future Plans
Table 86. Avid Bioservices, Inc. Company Information, Head Office, and Major Competitors
Table 87. Avid Bioservices, Inc. Major Business
Table 88. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 89. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Avid Bioservices, Inc. Recent Developments and Future Plans
Table 91. Recipharm Advanced Bio Company Information, Head Office, and Major Competitors
Table 92. Recipharm Advanced Bio Major Business
Table 93. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 94. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Recipharm Advanced Bio Recent Developments and Future Plans
Table 96. Ajinomoto Bio-Pharma Services Company Information, Head Office, and Major Competitors
Table 97. Ajinomoto Bio-Pharma Services Major Business
Table 98. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 99. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
Table 101. Wacker Biotech GmbH Company Information, Head Office, and Major Competitors
Table 102. Wacker Biotech GmbH Major Business
Table 103. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 104. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Wacker Biotech GmbH Recent Developments and Future Plans
Table 106. Bora Biologics Company Information, Head Office, and Major Competitors
Table 107. Bora Biologics Major Business
Table 108. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 109. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Bora Biologics Recent Developments and Future Plans
Table 111. 3PBIOVIAN Company Information, Head Office, and Major Competitors
Table 112. 3PBIOVIAN Major Business
Table 113. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 114. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. 3PBIOVIAN Recent Developments and Future Plans
Table 116. Fareva Company Information, Head Office, and Major Competitors
Table 117. Fareva Major Business
Table 118. Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 119. Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Fareva Recent Developments and Future Plans
Table 121. Aenova Group Company Information, Head Office, and Major Competitors
Table 122. Aenova Group Major Business
Table 123. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 124. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Aenova Group Recent Developments and Future Plans
Table 126. Siegfried Holding AG Company Information, Head Office, and Major Competitors
Table 127. Siegfried Holding AG Major Business
Table 128. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 129. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Siegfried Holding AG Recent Developments and Future Plans
Table 131. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 132. GenScript ProBio Major Business
Table 133. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 134. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. GenScript ProBio Recent Developments and Future Plans
Table 136. Chime Biologics (Wuhan) Co., Ltd. Company Information, Head Office, and Major Competitors
Table 137. Chime Biologics (Wuhan) Co., Ltd. Major Business
Table 138. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 139. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Chime Biologics (Wuhan) Co., Ltd. Recent Developments and Future Plans
Table 141. MabPlex International Company Information, Head Office, and Major Competitors
Table 142. MabPlex International Major Business
Table 143. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 144. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. MabPlex International Recent Developments and Future Plans
Table 146. Pharmaron Beijing Co., Ltd. Company Information, Head Office, and Major Competitors
Table 147. Pharmaron Beijing Co., Ltd. Major Business
Table 148. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 149. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Pharmaron Beijing Co., Ltd. Recent Developments and Future Plans
Table 151. Thousand Oaks Biologics Inc. Company Information, Head Office, and Major Competitors
Table 152. Thousand Oaks Biologics Inc. Major Business
Table 153. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 154. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Thousand Oaks Biologics Inc. Recent Developments and Future Plans
Table 156. Cytovance Biologics, Inc. Company Information, Head Office, and Major Competitors
Table 157. Cytovance Biologics, Inc. Major Business
Table 158. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 159. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Cytovance Biologics, Inc. Recent Developments and Future Plans
Table 161. Porton Pharma Solutions Ltd. Company Information, Head Office, and Major Competitors
Table 162. Porton Pharma Solutions Ltd. Major Business
Table 163. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 164. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. Porton Pharma Solutions Ltd. Recent Developments and Future Plans
Table 166. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million) by Players (2021-2026)
Table 167. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Share by Players (2021-2026)
Table 168. Breakdown of Biologics CMO (Contract Manufacturing Organization) Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 169. Market Position of Players in Biologics CMO (Contract Manufacturing Organization) Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 170. Head Office of Key Biologics CMO (Contract Manufacturing Organization) Services Players
Table 171. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
Table 172. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
Table 173. Biologics CMO (Contract Manufacturing Organization) Services New Market Entrants and Barriers to Market Entry
Table 174. Biologics CMO (Contract Manufacturing Organization) Services Mergers, Acquisition, Agreements, and Collaborations
Table 175. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (USD Million) by Type (2021-2026)
Table 176. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Share by Type (2021-2026)
Table 177. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Type (2027-2032)
Table 178. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026)
Table 179. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Application (2027-2032)
Table 180. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 181. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 182. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 183. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 184. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 185. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 186. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 187. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 188. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 189. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 190. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 191. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 192. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 193. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 194. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 195. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 196. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 197. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2027-2032) & (USD Million)
Table 198. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 199. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 200. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 201. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 202. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 203. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 204. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 205. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 206. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 207. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 208. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 209. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 210. Global Key Players of Biologics CMO (Contract Manufacturing Organization) Services Upstream (Raw Materials)
Table 211. Global Biologics CMO (Contract Manufacturing Organization) Services Typical Customers
Table 1. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 8. Lonza Group AG Major Business
Table 9. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 10. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Lonza Group AG Recent Developments and Future Plans
Table 12. Samsung Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 13. Samsung Biologics Co., Ltd. Major Business
Table 14. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 15. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Samsung Biologics Co., Ltd. Recent Developments and Future Plans
Table 17. FUJIFILM Biotechnologies Company Information, Head Office, and Major Competitors
Table 18. FUJIFILM Biotechnologies Major Business
Table 19. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 20. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Boehringer Ingelheim BioXcellence Company Information, Head Office, and Major Competitors
Table 22. Boehringer Ingelheim BioXcellence Major Business
Table 23. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 24. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
Table 26. WuXi Biologics (Cayman) Inc. Company Information, Head Office, and Major Competitors
Table 27. WuXi Biologics (Cayman) Inc. Major Business
Table 28. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 29. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. WuXi Biologics (Cayman) Inc. Recent Developments and Future Plans
Table 31. Thermo Fisher Scientific – Patheon Pharma Services Company Information, Head Office, and Major Competitors
Table 32. Thermo Fisher Scientific – Patheon Pharma Services Major Business
Table 33. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 34. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Thermo Fisher Scientific – Patheon Pharma Services Recent Developments and Future Plans
Table 36. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 37. Catalent, Inc. Major Business
Table 38. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 39. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Catalent, Inc. Recent Developments and Future Plans
Table 41. AGC Biologics Company Information, Head Office, and Major Competitors
Table 42. AGC Biologics Major Business
Table 43. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 44. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. AGC Biologics Recent Developments and Future Plans
Table 46. National Resilience, Inc. Company Information, Head Office, and Major Competitors
Table 47. National Resilience, Inc. Major Business
Table 48. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 49. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. National Resilience, Inc. Recent Developments and Future Plans
Table 51. Vetter Pharma International GmbH Company Information, Head Office, and Major Competitors
Table 52. Vetter Pharma International GmbH Major Business
Table 53. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 54. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Vetter Pharma International GmbH Recent Developments and Future Plans
Table 56. Rentschler Biopharma SE Company Information, Head Office, and Major Competitors
Table 57. Rentschler Biopharma SE Major Business
Table 58. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 59. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Rentschler Biopharma SE Recent Developments and Future Plans
Table 61. KBI Biopharma, Inc. Company Information, Head Office, and Major Competitors
Table 62. KBI Biopharma, Inc. Major Business
Table 63. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 64. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. KBI Biopharma, Inc. Recent Developments and Future Plans
Table 66. LOTTE BIOLOGICS Co., Ltd. Company Information, Head Office, and Major Competitors
Table 67. LOTTE BIOLOGICS Co., Ltd. Major Business
Table 68. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 69. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. LOTTE BIOLOGICS Co., Ltd. Recent Developments and Future Plans
Table 71. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 72. Pfizer CentreOne Major Business
Table 73. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 74. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Pfizer CentreOne Recent Developments and Future Plans
Table 76. AbbVie Contract Manufacturing Company Information, Head Office, and Major Competitors
Table 77. AbbVie Contract Manufacturing Major Business
Table 78. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 79. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. AbbVie Contract Manufacturing Recent Developments and Future Plans
Table 81. Syngene International Limited Company Information, Head Office, and Major Competitors
Table 82. Syngene International Limited Major Business
Table 83. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 84. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Syngene International Limited Recent Developments and Future Plans
Table 86. Avid Bioservices, Inc. Company Information, Head Office, and Major Competitors
Table 87. Avid Bioservices, Inc. Major Business
Table 88. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 89. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Avid Bioservices, Inc. Recent Developments and Future Plans
Table 91. Recipharm Advanced Bio Company Information, Head Office, and Major Competitors
Table 92. Recipharm Advanced Bio Major Business
Table 93. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 94. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Recipharm Advanced Bio Recent Developments and Future Plans
Table 96. Ajinomoto Bio-Pharma Services Company Information, Head Office, and Major Competitors
Table 97. Ajinomoto Bio-Pharma Services Major Business
Table 98. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 99. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
Table 101. Wacker Biotech GmbH Company Information, Head Office, and Major Competitors
Table 102. Wacker Biotech GmbH Major Business
Table 103. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 104. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Wacker Biotech GmbH Recent Developments and Future Plans
Table 106. Bora Biologics Company Information, Head Office, and Major Competitors
Table 107. Bora Biologics Major Business
Table 108. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 109. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Bora Biologics Recent Developments and Future Plans
Table 111. 3PBIOVIAN Company Information, Head Office, and Major Competitors
Table 112. 3PBIOVIAN Major Business
Table 113. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 114. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. 3PBIOVIAN Recent Developments and Future Plans
Table 116. Fareva Company Information, Head Office, and Major Competitors
Table 117. Fareva Major Business
Table 118. Fareva Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 119. Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Fareva Recent Developments and Future Plans
Table 121. Aenova Group Company Information, Head Office, and Major Competitors
Table 122. Aenova Group Major Business
Table 123. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 124. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Aenova Group Recent Developments and Future Plans
Table 126. Siegfried Holding AG Company Information, Head Office, and Major Competitors
Table 127. Siegfried Holding AG Major Business
Table 128. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 129. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Siegfried Holding AG Recent Developments and Future Plans
Table 131. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 132. GenScript ProBio Major Business
Table 133. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 134. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. GenScript ProBio Recent Developments and Future Plans
Table 136. Chime Biologics (Wuhan) Co., Ltd. Company Information, Head Office, and Major Competitors
Table 137. Chime Biologics (Wuhan) Co., Ltd. Major Business
Table 138. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 139. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Chime Biologics (Wuhan) Co., Ltd. Recent Developments and Future Plans
Table 141. MabPlex International Company Information, Head Office, and Major Competitors
Table 142. MabPlex International Major Business
Table 143. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 144. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. MabPlex International Recent Developments and Future Plans
Table 146. Pharmaron Beijing Co., Ltd. Company Information, Head Office, and Major Competitors
Table 147. Pharmaron Beijing Co., Ltd. Major Business
Table 148. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 149. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Pharmaron Beijing Co., Ltd. Recent Developments and Future Plans
Table 151. Thousand Oaks Biologics Inc. Company Information, Head Office, and Major Competitors
Table 152. Thousand Oaks Biologics Inc. Major Business
Table 153. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 154. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Thousand Oaks Biologics Inc. Recent Developments and Future Plans
Table 156. Cytovance Biologics, Inc. Company Information, Head Office, and Major Competitors
Table 157. Cytovance Biologics, Inc. Major Business
Table 158. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 159. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Cytovance Biologics, Inc. Recent Developments and Future Plans
Table 161. Porton Pharma Solutions Ltd. Company Information, Head Office, and Major Competitors
Table 162. Porton Pharma Solutions Ltd. Major Business
Table 163. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product and Solutions
Table 164. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. Porton Pharma Solutions Ltd. Recent Developments and Future Plans
Table 166. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue (USD Million) by Players (2021-2026)
Table 167. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Share by Players (2021-2026)
Table 168. Breakdown of Biologics CMO (Contract Manufacturing Organization) Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 169. Market Position of Players in Biologics CMO (Contract Manufacturing Organization) Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 170. Head Office of Key Biologics CMO (Contract Manufacturing Organization) Services Players
Table 171. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Type Footprint
Table 172. Biologics CMO (Contract Manufacturing Organization) Services Market: Company Product Application Footprint
Table 173. Biologics CMO (Contract Manufacturing Organization) Services New Market Entrants and Barriers to Market Entry
Table 174. Biologics CMO (Contract Manufacturing Organization) Services Mergers, Acquisition, Agreements, and Collaborations
Table 175. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (USD Million) by Type (2021-2026)
Table 176. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Share by Type (2021-2026)
Table 177. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Type (2027-2032)
Table 178. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026)
Table 179. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Forecast by Application (2027-2032)
Table 180. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 181. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 182. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 183. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 184. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 185. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 186. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 187. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 188. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 189. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 190. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 191. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 192. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 193. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 194. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 195. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 196. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2021-2026) & (USD Million)
Table 197. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Region (2027-2032) & (USD Million)
Table 198. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 199. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 200. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 201. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 202. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 203. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 204. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2021-2026) & (USD Million)
Table 205. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type (2027-2032) & (USD Million)
Table 206. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2021-2026) & (USD Million)
Table 207. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application (2027-2032) & (USD Million)
Table 208. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2021-2026) & (USD Million)
Table 209. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Country (2027-2032) & (USD Million)
Table 210. Global Key Players of Biologics CMO (Contract Manufacturing Organization) Services Upstream (Raw Materials)
Table 211. Global Biologics CMO (Contract Manufacturing Organization) Services Typical Customers
LIST OF FIGURES
Figure 1. Biologics CMO (Contract Manufacturing Organization) Services Picture
Figure 2. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type in 2025
Figure 4. Cell and Gene Therapies
Figure 5. Antibodies
Figure 6. Vaccines
Figure 7. Others
Figure 8. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by CMO Provider Type in 2025
Figure 10. In-house CMO
Figure 11. Independent CMO
Figure 12. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Manufacturing Stage in 2025
Figure 14. Drug Substance (DS) Manufacturing
Figure 15. Drug Product (DP) Manufacturing
Figure 16. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application in 2025
Figure 18. Large Pharmaceutical and Biopharmaceutical Companies Picture
Figure 19. Small and Mid-sized Pharmaceutical and Biotechnology Companies Picture
Figure 20. Others Picture
Figure 21. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region in 2025
Figure 26. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Share by Players in 2025
Figure 33. Biologics CMO (Contract Manufacturing Organization) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Biologics CMO (Contract Manufacturing Organization) Services by Player Revenue in 2025
Figure 35. Top 3 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
Figure 36. Top 6 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
Figure 37. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Share by Type (2021-2026)
Figure 38. Global Biologics CMO (Contract Manufacturing Organization) Services Market Share Forecast by Type (2027-2032)
Figure 39. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Share by Application (2021-2026)
Figure 40. Global Biologics CMO (Contract Manufacturing Organization) Services Market Share Forecast by Application (2027-2032)
Figure 41. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 51. France Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region (2021-2032)
Figure 58. China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 61. India Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 75. Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
Figure 76. Biologics CMO (Contract Manufacturing Organization) Services Market Restraints
Figure 77. Biologics CMO (Contract Manufacturing Organization) Services Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Biologics CMO (Contract Manufacturing Organization) Services Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source
Figure 1. Biologics CMO (Contract Manufacturing Organization) Services Picture
Figure 2. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type in 2025
Figure 4. Cell and Gene Therapies
Figure 5. Antibodies
Figure 6. Vaccines
Figure 7. Others
Figure 8. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by CMO Provider Type, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by CMO Provider Type in 2025
Figure 10. In-house CMO
Figure 11. Independent CMO
Figure 12. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Manufacturing Stage, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Manufacturing Stage in 2025
Figure 14. Drug Substance (DS) Manufacturing
Figure 15. Drug Product (DP) Manufacturing
Figure 16. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application in 2025
Figure 18. Large Pharmaceutical and Biopharmaceutical Companies Picture
Figure 19. Small and Mid-sized Pharmaceutical and Biotechnology Companies Picture
Figure 20. Others Picture
Figure 21. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region in 2025
Figure 26. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Share by Players in 2025
Figure 33. Biologics CMO (Contract Manufacturing Organization) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Biologics CMO (Contract Manufacturing Organization) Services by Player Revenue in 2025
Figure 35. Top 3 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
Figure 36. Top 6 Biologics CMO (Contract Manufacturing Organization) Services Players Market Share in 2025
Figure 37. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Share by Type (2021-2026)
Figure 38. Global Biologics CMO (Contract Manufacturing Organization) Services Market Share Forecast by Type (2027-2032)
Figure 39. Global Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Share by Application (2021-2026)
Figure 40. Global Biologics CMO (Contract Manufacturing Organization) Services Market Share Forecast by Application (2027-2032)
Figure 41. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 51. France Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Region (2021-2032)
Figure 58. China Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 61. India Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Biologics CMO (Contract Manufacturing Organization) Services Consumption Value (2021-2032) & (USD Million)
Figure 75. Biologics CMO (Contract Manufacturing Organization) Services Market Drivers
Figure 76. Biologics CMO (Contract Manufacturing Organization) Services Market Restraints
Figure 77. Biologics CMO (Contract Manufacturing Organization) Services Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Biologics CMO (Contract Manufacturing Organization) Services Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source
